Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets
商品番号 : SMB-79159
| 出版社 | BCC Research |
| 出版年月 | 2025年5月 |
| ページ数 | 155 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,650 |
| 種別 | 英文調査報告書 |
本レポートは、世界の市販薬（OTC）・ビタミン剤・栄養補助食品市場の概要を示し、市場動向を分析しています。2024年を基準年とする世界市場全体の売上高（百万米ドル）、2025年の推定市場価値、そして2025年から2030年の予測期間における市場価値を網羅しています。本レポートにおける市場売上高とは、工場渡し価格またはメーカー渡し価格を指し、卸売業者や小売業者による値上げ前の商品価格を表しています。
本レポートは、OTC医薬品・ビタミン剤・栄養補助食品市場とそのベンダー動向に影響を与える主要な動向と課題に焦点を当てています。また、この市場における最新の新製品、買収、提携についても取り上げています。さらに、環境・社会・コーポレートガバナンス（ESG）の動向を分析し、市場に関連する新たな機会と課題についても考察しています。
Report Highlights
The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.
市販薬（OTC）やビタミン、栄養補助食品の世界市場は、2025年の2,769億ドルから2030年末までに3,717億ドルに達すると予想されており、2025年から2030年の予測期間中、年平均成長率（CAGR）は6.1%となる見込みです。
Summary:
Over-the-counter (OTC) medicines are nonprescription medications that individuals can purchase directly without a doctor’s prescription. OTC drugs effectively treat various disorders and their associated symptoms, including pain, coughs, colds, diarrhea, constipation and acne. Vitamins and dietary supplements are intended to provide essential nutrients to fill potential gaps in a person’s diet for maintaining an active and healthy lifestyle. Common dietary supplements include vitamins, minerals, herbs and botanicals, probiotics, fish oil and more. To capture product-specific nuances, this report, where relevant, treats the OTC drugs market as being distinct from the vitamins and drug supplement
market in its analysis.
Key players in the global OTC drugs, vitamins and dietary supplements market include Haleon Group of Companies, Kenvue, Opella Healthcare Group SAS, Bayer, Procter & Gamble, Reckitt, STADA Arzneimittel AG, Amway, Nestlé, Pharmavite, H&H Group, Herbalife, Church & Dwight and GNC Holdings. The market is highly fragmented. In addition to industry leaders, domestic players and store brands also play a vital role. Companies compete in terms of pricing strategies, product quality, innovation, brand recognition and distribution channels.
Segmental Analysis
In this report, the global OTC drugs, vitamins and dietary supplements market is segmented based on product type, point of sale and geographic region. Whereas vitamins and dietary supplements are treated as their own product type segment, OTC drugs are further segmented by product type into respiratory treatments, pain relief, digestive health, dermatological drugs, oral medical care, eye care and smoking cessation. Similarly, whereas the vitamins and dietary supplements market is categorized based on point of sale into the following segments: retail pharmacies and stores, e-commerce and other points of sale; the OTC drugs market is categorized as retail pharmacies and stores as well as epharmacies.
Report Scope
This report provides an overview of the global over-the-counter (OTC) drugs, vitamins and dietary supplements market and analyzes trends in this market. It includes global revenue ($ million) for the base year of 2024, estimated market values for 2025, and market values for the forecast period 2025 through 2030. In this report, market revenue refers to ex-factory or ex-manufacturer sales, representing the value of goods as they leave the manufacturer and before any markups by wholesalers or retailers.
The report focuses on the major driving trends and challenges that affect the OTC drugs, vitamins and dietary supplements market and its vendor landscape. It covers the latest new products, acquisitions and collaborations taking place in this market. It also analyzes environmental, social, and corporate governance (ESG) developments and discusses emerging opportunities and challenges related to the market.
The report concludes with an analysis of the competitive landscape of this market, providing the ranking and share of key players. It also has a company profiles section that is dedicated to providing details about leading market players.
It is important to note that this report’s scope covers only pharmacological OTC drugs and excludes any other types of drugs, such as alternative therapies. Also, dietary supplements for weight management, meal replacements, medical nutrition, sports nutrition, and skin care are not included in this report.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||
| Base year market size | $262.8 Billion | ||||||||||||||||
| Market size forecast | $371.7 Billion | ||||||||||||||||
| Growth rate | CAGR of 6.1% for the forecast period of 2025-2030 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Product Type, Point of Sale, and Region | ||||||||||||||||
| Regions covered | North America, Asia-Pacific, Europe, South America, and Middle East and Africa | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, and China | ||||||||||||||||
| Key Market Drivers |
| ||||||||||||||||
| Companies studied |
| ||||||||||||||||
Report Includes
– 46 data tables and 59 additional tables
– An overview of the global market for over-the-counter drugs, vitamins and dietary supplements
– An analysis of the global market trends with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
– Highlights of the current and future market potential and quantification of the market by product type, point of sales, and geographic region
– Discussion on market opportunities for over-the-counter drugs, vitamins and dietary supplement applications, industry structure, and regulatory scenarios
– Information on the latest developments in healthcare interoperability solutions and new industry research, upcoming technologies, and economic trends
– Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
– Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
– Comprehensive company profiles of the leading players of the industry, including Haleon Group of Companies, Kenvue, Opella Healthcare Group SAS, Bayer AG, and Procter & Gamble
Table of Contents
Chapter 1 Executive Summary
Scope of Report
Market Summary
Chapter 2 Market Overview
Market Definitions
Over-the-counter (OTC) Drugs
Vitamins and Dietary Supplements
Industry Overview
Macroeconomic Analysis
Porter’s Five Forces Analysis
Bargaining Power of Buyers (High)
Bargaining Power of Suppliers (Moderate to Low)
Threat of New Entrants (Moderate)
Threat of Substitutes (Low)
Industry Competition (High)
Chapter 3 Market Dynamics
Market Drivers
Increasing Trend Toward Self-Care and Preventive Care
Changing Demographics Resulting in Aging Population
Increasing Pressure on Public Health Systems
Premiumization and Innovation Driving Pricing
Rising Online Sales Channels and Growth of Telehealth Platforms
Market Restraints
Increases in the Availability and Acceptance of Private-Label Brands
Threat from Counterfeit Products
Presence of Alternative Methods
Impact of Seasonality
Market Opportunities
Growing Middle Class in Emerging Economies
Growing Demand for Women’s Health and Cognitive Health Support Products
Shift Toward Herbal and Organic Products
E-Commerce and Direct-to-Consumer Sales
Key Takeaways
Chapter 4 Regulatory Landscape
U.S.
OTC Drugs
Vitamins and Dietary Supplements
Europe
OTC Drugs
Vitamins and Dietary Supplements
Asia-Pacific
OTC Drugs
Vitamins and Dietary Supplements
Chapter 5 Emerging Technologies and Developments
Increased Awareness of Ingredient Labeling
Brand Extension Fueled by Innovation
Rx-to-OTC Switch
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
OTC Drugs, Vitamins and Dietary Supplements Market, by Product Type
Vitamins and Dietary Supplements
Market Overview
Key Takeaways
Market Revenue and Forecast
Vitamins and Dietary Supplements Market, by Point of Sale
Retail Pharmacies and Stores
E-Commerce
Other Points of Sales
OTC Drugs
Market Overview
Key Takeaways
Market Revenue and Forecast, by Product Type
Respiratory Treatments
Pain Relief
Digestive Health
Dermatological Drugs
Oral Medical Care
Eye Care
Smoking Cessation
OTC Drugs Market, by Point of Sale
Retail Pharmacies and Stores
E-Pharmacies
Geographic Breakdown
OTC Drugs, Vitamins and Dietary Supplements Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 7 Competitive Intelligence
Key Takeaways
OTC Drugs
Vitamins and Dietary Supplements
Key Developments and Strategies
Chapter 8 Sustainability in OTC Drugs, Vitamins and Dietary Supplements Market: ESG Perspective
Introduction to ESG
Environment
Social
Governance
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AMWAY CORP.
BAYER AG
DSM- FIRMENICH
HALEON GROUP OF CO.
HERBALIFE LTD.
KENVUE
NESTLE HEALTH SCIENCE
OPELLA HEALTHCARE GROUP SAS
PHARMAVITE
PROCTER & GAMBLE
RECKITT
STADA ARZNEIMITTEL AG
TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Emerging Start-ups/ Market Disruptors
List of Tables
Summary Table : Global Market for OTC Drugs, Vitamins and Dietary Supplements, by Region, Through 2030
Table 1 : Benefits of Over-the-Counter (OTC) Drugs
Table 2 : Porter’s Five Forces: Rating Scale
Table 3 : Number and Proportion of Persons Aged 65 Years and Over, by Development Group, 2023 and 2050
Table 4 : Asia-Pacific: Regulatory Landscape
Table 5 : Rx-to-OTC Switch Drugs, 2020–2024*
Table 6 : Global Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 7 : Common Dietary Supplements
Table 8 : Specialty Dietary Supplements
Table 9 : Global Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 10 : Global Market for OTC Drugs, by Product Type, Through 2030
Table 11 : Common OTC Respiratory Drugs
Table 12 : Most Common OTC Pain Relievers
Table 13 : Digestive Health OTC Drugs
Table 14 : Most Common OTC Dermatological Drugs
Table 15 : OTC Eye Care Drugs
Table 16 : OTC Smoking Cessation Products
Table 17 : Global Market for OTC Drugs, by Point of Sale, Through 2030
Table 18 : Global Market for OTC Drugs, Vitamins and Dietary Supplements, by Region, Through 2030
Table 19 : North American Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 20 : North American Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 21 : North American Market for OTC Drugs, by Point of Sale, Through 2030
Table 22 : North American Population and GDP Data, by Country, 2023
Table 23 : U.S. Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 24 : Canadian Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 25 : Mexican Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 26 : European Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 27 : European Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 28 : European Market for OTC Drugs, by Point of Sale, Through 2030
Table 29 : German Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 30 : U.K. Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 31 : French Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 32 : Italian Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 33 : Rest of European Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 34 : Asia-Pacific Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 35 : Asia-Pacific Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 36 : Asia-Pacific Market for OTC Drugs, by Point of Sale, Through 2030
Table 37 : Chinese Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 38 : Japanese Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 39 : Indian Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 40 : Rest of APAC Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 41 : Middle Eastern and African Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 42 : Middle Eastern and African Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 43 : Middle Eastern and African Market for OTC Drugs, by Point of Sale, Through 2030
Table 44 : South American Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 45 : South American Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 46 : South American Market for OTC Drugs, by Point of Sale, Through 2030
Table 47 : OTC Drugs: Market Player Share Analysis, 2024
Table 48 : Leading Vitamin and Dietary Supplement Companies and Their Key Brands, 2024
Table 49 : Key Developments and Strategies, 2023-2025
Table 50 : ESG Pillars for OTC Drugs, Vitamins and Dietary Supplements Market
Table 51 : ESG Risk Rankings for OTC Drugs, Vitamins and Dietary Supplements Companies, 2025*
Table 52 : Report Sources
Table 53 : Abbreviations Used in This Report
Table 54 : Abbott: Company Snapshot
Table 55 : Abbott: Financial Performance, FY 2023 and 2024
Table 56 : Abbott: Product Portfolio
Table 57 : Amway Corp.: Company Snapshot
Table 58 : Amway Corp.: Product Portfolio
Table 59 : Bayer AG: Company Snapshot
Table 60 : Bayer AG: Financial Performance, FY 2023 and 2024
Table 61 : Bayer AG: Product Portfolio
Table 62 : Bayer AG: News/Key Developments, 2024 and 2025
Table 63 : DSM-Firmenich: Company Snapshot
Table 64 : DSM-Firmenich: Financial Performance, FY 2023 and 2024
Table 65 : DSM-Firmenich: Product Portfolio
Table 66 : DSM-Firmenich: News/Key Developments, 2023 and 2024
Table 67 : Haleon Group of Co.: Company Snapshot
Table 68 : Haleon Group of Co.: Financial Performance, FY 2023 and 2024
Table 69 : Haleon Group of Co.: Product Portfolio
Table 70 : Haleon Group of Co.: News/Key Developments, 2023
Table 71 : Herbalife Ltd.: Company Snapshot
Table 72 : Herbalife Ltd.: Financial Performance, FY 2023 and 2024
Table 73 : Herbalife Ltd.: Product Portfolio
Table 74 : Herbalife Ltd.: News/Key Developments, 2023
Table 75 : Kenvue: Company Snapshot
Table 76 : Kenvue: Financial Performance, FY 2023 and 2024
Table 77 : Kenvue: Product Portfolio
Table 78 : Kenvue: News/Key Developments, 2023
Table 79 : Nestlé Health Science: Company Snapshot
Table 80 : Nestlé Health Science: Financial Performance, FY 2023 and 2024
Table 81 : Nestlé Health Science: Product Portfolio
Table 82 : Opella Healthcare Group SAS: Company Snapshot
Table 83 : Opella Healthcare Group SAS: Product Portfolio
Table 84 : Opella Healthcare Group SAS: News/Key Developments, 2023-2025
Table 85 : Pharmavite: Company Snapshot
Table 86 : Pharmavite: Product Portfolio
Table 87 : Pharmavite: News/Key Developments, 2023 and 2024
Table 88 : Procter & Gamble: Company Snapshot
Table 89 : Procter & Gamble: Financial Performance, FY 2022 and 2023
Table 90 : Procter & Gamble: Product Portfolio
Table 91 : Reckitt: Company Snapshot
Table 92 : Reckitt: Financial Performance, FY 2023 and 2024
Table 93 : Reckitt: Product Portfolio
Table 94 : Reckitt: News/Key Developments, 2024
Table 95 : Stada Arzneimittel AG: Company Snapshot
Table 96 : Stada Arzneimittel AG: Financial Performance, FY 2022 and 2023
Table 97 : Stada Arzneimittel AG: Product Portfolio
Table 98 : Stada Arzneimittel AG: News/Key Developments, 2023 and 2024
Table 99 : Taisho Pharmaceutical Holdings Co. Ltd.: Company Snapshot
Table 100 : Taisho Pharmaceutical Holdings Co. Ltd.: Product Portfolio
Table 101 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 102 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2023 and 2024
Table 103 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 104 : List of Few Emerging Startups/ Market Disruptors
List of Figures
Summary Figure : Global Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Region, 2024
Figure 1 : Porter’s Five Forces Analysis
Figure 2 : Market Dynamics Snapshot
Figure 3 : Global Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 4 : Global Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 5 : Global Market Shares of OTC Drugs, by Product Type, 2024
Figure 6 : Global Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 7 : Global Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Region, 2024
Figure 8 : North American Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 9 : North American Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 10 : North American Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 11 : U.S. Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 12 : Canadian Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 13 : Mexican Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 14 : European Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 15 : European Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 16 : European Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 17 : German Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 18 : U.K. Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 19 : French Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 20 : Italian Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 21 : Rest of European Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 22 : Asia-Pacific Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 23 : Asia-Pacific Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 24 : Asia-Pacific Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 25 : Chinese Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 26 : Japanese Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 27 : Indian Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 28 : Rest of APAC Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 29 : Middle Eastern and African Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 30 : Middle Eastern and African Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 31 : Middle Eastern and African Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 32 : South American Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 33 : South American Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 34 : South American Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 35 : Abbott: Revenue Shares, by Business Unit, FY 2024
Figure 36 : Abbott: Revenue Shares, by Country/Region, FY 2024
Figure 37 : Bayer AG: Revenue Shares, by Business Unit, FY 2024
Figure 38 : Bayer AG: Revenue Shares, by Country/Region, FY 2024
Figure 39 : DSM-Firmenich: Revenue Shares, by Business Unit, FY 2024
Figure 40 : DSM-Firmenich: Revenue Shares, by Country/Region, FY 2024
Figure 41 : Haleon Group of Co.: Revenue Shares, by Business Unit, FY 2024
Figure 42 : Haleon Group of Co.: Revenue Shares, by Country/Region, FY 2024
Figure 43 : Herbalife Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 44 : Herbalife Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 45 : Kenvue: Revenue Shares, by Business Unit, FY 2024
Figure 46 : Kenvue: Revenue Shares, by Country/Region, FY 2024
Figure 47 : Procter & Gamble: Revenue Shares, by Business Unit, FY 2023
Figure 48 : Procter & Gamble: Revenue Shares, by Country/Region, FY 2023
Figure 49 : Reckitt: Revenue Shares, by Business Unit, FY 2024
Figure 50 : Reckitt: Revenue Shares, by Country/ Region, FY 2024
Figure 51 : Stada Arzneimittel AG: Revenue Shares, by Business Unit, FY 2023
Figure 52 : Stada Arzneimittel AG: Revenue Shares, by Country/ Region, FY 2023
Figure 53 : Teva Pharmaceutical Industries Ltd.: Market Shares, by Business Unit, 2024
BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自律型無人潜水機の2030年までの世界市場 2025-06-06
- 世界のSDV(ソフトウェア・デファインド・ビークル)市場 2025-06-06
- 高分子発泡体の世界市場 2025-06-06
- 世界の細胞株と細胞膜市場 2025-06-05
- 世界のエッジAI市場 2025-06-03
